US 10716782
LPT-723 and immune checkpoint inhibitor combinations and methods of treatment
granted A61KA61K2039/507A61K31/444
Quick answer
US patent 10716782 (LPT-723 and immune checkpoint inhibitor combinations and methods of treatment) held by Biomed Valley Discoveries, Inc. expires Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Biomed Valley Discoveries, Inc.
- Grant date
- Tue Jul 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/507, A61K31/444, A61K39/3955, A61K39/39558